| # | Drug | Count |
|---|---|---|
| 0 | LEVONORGESTREL | 77 |
| 1 | ADALIMUMAB | 36 |
| 2 | BEVACIZUMAB | 34 |
| 3 | PREDNISONE | 33 |
| 4 | CAPECITABINE | 31 |
| 5 | OXALIPLATIN | 29 |
| 6 | COPPER | 24 |
| 7 | CYCLOPHOSPHAMIDE | 24 |
| 8 | CYCLOPHOSPHAMIDE FOR INJECTION | 24 |
| 9 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 24 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | POTASSIUM CHLORIDE AND SODIUM CHLORIDE | 6 | 0.1000 |
| 1 | HUMAN FIBRINOGEN, HUMAN THROMBIN | 3 | 0.0517 |
| 2 | ENSARTINIB | 1 | 0.0222 |
| 3 | NAFARELIN ACETATE | 6 | 0.0220 |
| 4 | CETRORELIX ACETATE | 10 | 0.0158 |
| 5 | GONADOTROPHIN, CHORIONIC | 6 | 0.0097 |
| 6 | FOLLITROPIN ALFA | 17 | 0.0083 |
| 7 | GANIRELIX ACETATE | 6 | 0.0079 |
| 8 | BENZETHONIUM CHLORIDE | 1 | 0.0078 |
| 9 | CHORIOGONADOTROPIN ALFA | 19 | 0.0073 |
| # | Drug class | Count |
|---|---|---|
| 0 | Progestin [EPC] | 85 |
| 1 | Progestin-containing Intrauterine System [EPC] | 77 |
| 2 | Platinum-based Drug [EPC] | 65 |
| 3 | Corticosteroid [EPC] | 64 |
| 4 | Nucleoside Metabolic Inhibitor [EPC] | 54 |
| 5 | Nonsteroidal Anti-inflammatory Drug [EPC] | 44 |
| 6 | Kinase Inhibitor [EPC] | 41 |
| 7 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 41 |
| 8 | Alkylating Drug [EPC] | 35 |
| 9 | Osmotic Laxative [EPC] | 32 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Gonadotropin [EPC] | 18 | 0.0082 |
| 1 | Cholecystokinin Analog [EPC] | 1 | 0.0065 |
| 2 | Human Blood Coagulation Factor [EPC] | 3 | 0.0036 |
| 3 | Plasma Kallikrein Inhibitor [EPC] | 4 | 0.0017 |
| 4 | Anthracycline Topoisomerase Inhibitor [EPC] | 3 | 0.0012 |
| 5 | Isocitrate Dehydrogenase 1 Inhibitor [EPC] | 2 | 0.0009 |
| 6 | Vitamin K [EPC] | 7 | 0.0008 |
| 7 | Progesterone [EPC] | 12 | 0.0005 |
| 8 | Copper-containing Intrauterine Device [EPC] | 24 | 0.0005 |
| 9 | Antiseptic [EPC] | 2 | 0.0005 |